Ekso Bionics Holdings, Inc. (LON:0IFR)

Ekso Bionics Holdings Statistics

Total Valuation

LON:0IFR has a market cap or net worth of GBP 24.06 million. The enterprise value is 25.70 million.

Market Cap	24.06M
Enterprise Value	25.70M

Important Dates

The next estimated earnings date is Wednesday, March 4, 2026.

Earnings Date	Mar 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.94M
Shares Outstanding	n/a
Shares Change (YoY)	+73.41%
Shares Change (QoQ)	+20.00%
Owned by Insiders (%)	14.53%
Owned by Institutions (%)	4.93%
Float	2.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.19
PB Ratio	3.34
P/TBV Ratio	6.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.24
EV / Sales	2.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.84

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.51.

Current Ratio	1.66
Quick Ratio	0.98
Debt / Equity	0.51
Debt / EBITDA	n/a
Debt / FCF	-0.55
Interest Coverage	-51.86

Financial Efficiency

Return on equity (ROE) is -85.01% and return on invested capital (ROIC) is -38.52%.

Return on Equity (ROE)	-85.01%
Return on Assets (ROA)	-27.15%
Return on Invested Capital (ROIC)	-38.52%
Return on Capital Employed (ROCE)	-86.83%
Weighted Average Cost of Capital (WACC)	13.09%
Revenue Per Employee	171,443
Profits Per Employee	-123,913
Employee Count	66
Asset Turnover	0.58
Inventory Turnover	1.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.41% in the last 52 weeks. The beta is 1.88, so LON:0IFR's price volatility has been higher than the market average.

Beta (5Y)	1.88
52-Week Price Change	-77.41%
50-Day Moving Average	6.40
200-Day Moving Average	15.95
Relative Strength Index (RSI)	35.17
Average Volume (20 Days)	2,110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.10

Income Statement

In the last 12 months, LON:0IFR had revenue of GBP 10.97 million and -7.93 million in losses. Loss per share was -3.90.

Revenue	10.97M
Gross Profit	5.87M
Operating Income	-8.22M
Pretax Income	-7.76M
Net Income	-7.93M
EBITDA	-7.09M
EBIT	-8.22M
Loss Per Share	-3.90

Balance Sheet

The company has 2.03 million in cash and 3.69 million in debt, with a net cash position of -1.66 million.

Cash & Cash Equivalents	2.03M
Total Debt	3.69M
Net Cash	-1.66M
Net Cash Per Share	n/a
Equity (Book Value)	7.20M
Book Value Per Share	2.75
Working Capital	4.36M

Cash Flow

In the last 12 months, operating cash flow was -6.62 million and capital expenditures -61,747, giving a free cash flow of -6.69 million.

Operating Cash Flow	-6.62M
Capital Expenditures	-61,747
Free Cash Flow	-6.69M
FCF Per Share	n/a

Margins

Gross margin is 53.48%, with operating and profit margins of -74.90% and -70.74%.

Gross Margin	53.48%
Operating Margin	-74.90%
Pretax Margin	-70.74%
Profit Margin	-70.74%
EBITDA Margin	-64.59%
EBIT Margin	-74.90%
FCF Margin	n/a

Dividends & Yields

LON:0IFR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-73.41%
Shareholder Yield	-73.41%
Earnings Yield	-32.95%
FCF Yield	-27.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 25, 2020. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Mar 25, 2020
Split Type	Reverse
Split Ratio	0.0666666667

Scores

LON:0IFR has an Altman Z-Score of -16.71 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-16.71
Piotroski F-Score	3